Disorders of phosphate homeostasis in children, part 2: hypophosphatemic and hyperphosphatemic disorders
- PMID: 35536416
- DOI: 10.1007/s00247-022-05373-z
Disorders of phosphate homeostasis in children, part 2: hypophosphatemic and hyperphosphatemic disorders
Abstract
Phosphorus, predominantly in the form of inorganic phosphate PO4-3, has many essential physiological functions. In the skeleton, phosphate and calcium form the mineral component and phosphate is also essential in regulating function of skeletal cells. Considerable advances have been made in our understanding of phosphate homeostasis since the recognition of fibroblast growth factor-23 (FGF23) as a bone-derived phosphaturic hormone. This second part of a two-part review of disorders of phosphate homeostasis in children covers hypophosphatemic and hyperphosphatemic disorders that are of interest to the pediatric radiologist, emphasizing, but not limited to, those related to abnormalities of FGF23 signaling.
Keywords: Bone; Children; Fibroblast growth factor-23; Hypophosphatemic rickets; Mineralization; Phosphate; Radiography.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Disorders of phosphate homeostasis in children, part 1: primer on mineral ion homeostasis and the roles of phosphate in skeletal biology.Pediatr Radiol. 2022 Nov;52(12):2278-2289. doi: 10.1007/s00247-022-05374-y. Epub 2022 May 10. Pediatr Radiol. 2022. PMID: 35536415 Review.
-
Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization.Curr Opin Nephrol Hypertens. 2007 Jul;16(4):329-35. doi: 10.1097/MNH.0b013e3281ca6ffd. Curr Opin Nephrol Hypertens. 2007. PMID: 17565275 Review.
-
Hypophosphatemic rickets: lessons from disrupted FGF23 control of phosphorus homeostasis.Curr Osteoporos Rep. 2015 Apr;13(2):88-97. doi: 10.1007/s11914-015-0259-y. Curr Osteoporos Rep. 2015. PMID: 25620749 Review.
-
FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization.Am J Physiol Endocrinol Metab. 2003 Jul;285(1):E1-9. doi: 10.1152/ajpendo.00016.2003. Am J Physiol Endocrinol Metab. 2003. PMID: 12791601 Review.
-
Advances in understanding of phosphate homeostasis and related disorders.Endocr J. 2022 Aug 29;69(8):881-896. doi: 10.1507/endocrj.EJ22-0239. Epub 2022 Jul 13. Endocr J. 2022. PMID: 35831119 Review.
Cited by
-
Experts' consensus on the management and treatment of individuals with X-linked hypophosphatemia across lifespan.J Endocrinol Invest. 2025 Jul 1. doi: 10.1007/s40618-025-02611-7. Online ahead of print. J Endocrinol Invest. 2025. PMID: 40591205
-
Relationship between serum phosphate and mortality in critically ill children receiving continuous renal replacement therapy.Front Pediatr. 2023 Apr 12;11:1129156. doi: 10.3389/fped.2023.1129156. eCollection 2023. Front Pediatr. 2023. PMID: 37124175 Free PMC article.
-
Diagnosis, treatment, and management of rickets: a position statement from the Bone and Mineral Metabolism Group of the Italian Society of Pediatric Endocrinology and Diabetology.Front Endocrinol (Lausanne). 2024 Apr 19;15:1383681. doi: 10.3389/fendo.2024.1383681. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38706696 Free PMC article. Review.
References
-
- ADHR Consortium (2000) Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet 26:345–348
-
- Levine BS, Kleeman CR, Felsenfeld AJ (2009) The journey from vitamin D-resistant rickets to the regulation of renal phosphate transport. Clin J Am Soc Nephrol 4:1866–1877 - PubMed
-
- Christov M, Jüppner H (2018) Phosphate homeostasis disorders. Best Pract Res Clin Endocrinol Metab 32:685–706 - PubMed
-
- Koumakis E, Cormier C, Roux C et al (2020) The causes of hypo- and hyperphosphatemia in humans. Calcif Tissue Int 108:41–73 - PubMed
-
- Michigami T, Ozono K (2019) Roles of phosphate in skeleton. Front Endocrinol 10:180
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources